Sunwang Xu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 7
- Epigenetics and DNA Methylation 6
- Circular RNAs in diseases 5
- Cancer-related gene regulation 4
-
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 9
- Cancer, Lipids, and Metabolism 5
- Co-authors
- Jian Wang (17 shared papers)Ming Zhan (17 shared papers)Man Mohan (6 shared papers)Wei Chen (6 shared papers)Shuai Huang (7 shared papers)Xince Huang (6 shared papers)Min He (6 shared papers)Manmei Long (5 shared papers)
- Journals
- Cell Death Discovery (5 papers)Cell Death and Disease (5 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Molecular Cancer (2 papers)Molecular Therapy — Oncolytics (1 paper)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Sunwang Xu
31 papers receiving 931 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 526
- Molecular Biology 679
- Oncology 243
- Pathology and Forensic Medicine 78
- Surgery 177
Countries citing papers authored by Sunwang Xu
This map shows the geographic impact of Sunwang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunwang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunwang Xu more than expected).
Fields of papers citing papers by Sunwang Xu
This network shows the impact of papers produced by Sunwang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunwang Xu. The network helps show where Sunwang Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Sunwang Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 90 | |
| 2 | 2019 | 77 | |
| 3 | 2020 | 76 | |
| 4 | 2019 | 71 | |
| 5 | 2019 | 70 | |
| 6 | 2017 | 69 | |
| 7 | 2017 | 58 | |
| 8 | 2016 | 48 | |
| 9 | 2017 | 46 | |
| 10 | 2017 | 39 | |
| 11 | 2018 | 38 | |
| 12 | 2017 | 36 | |
| 13 | 2018 | 34 | |
| 14 | 2015 | 26 | |
| 15 | 2023 | 23 | |
| 16 | 2019 | 17 | |
| 17 | 2023 | 15 | |
| 18 | 2024 | 14 | |
| 19 | 2019 | 13 | |
| 20 | 2024 | 13 |
About Sunwang Xu
Sunwang Xu is a scholar working on Molecular Biology, Cancer Research, Surgery, Oncology and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 939 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (7 papers), Epigenetics and DNA Methylation (6 papers), Cancer, Lipids, and Metabolism (5 papers), Circular RNAs in diseases (5 papers) and Cancer-related gene regulation (4 papers). The work is most often cited by research in Cancer Research (526 citations), Molecular Biology (679 citations), Oncology (243 citations), Pathology and Forensic Medicine (78 citations) and Surgery (177 citations). Sunwang Xu has collaborated with scholars based in China, United States and France. Frequent co-authors include Jian Wang, Ming Zhan, Man Mohan, Wei Chen, Shuai Huang, Xince Huang, Min He, Manmei Long, Ruirong Lin and Yongheng Shi. Their work appears in journals such as Cell Death Discovery, Cell Death and Disease, Journal of Experimental & Clinical Cancer Research, Molecular Cancer and Molecular Therapy — Oncolytics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.